10-Q: Non-Invasive Monitoring Systems Reports Q1 2025 Results, Cites Going Concern Uncertainty

Non-Invasive Monitoring Systems reports a net loss of $77,000 for the quarter ended October 31, 2024, and expresses substantial doubt about its ability to continue as a going concern.

Summary

• Non-Invasive Monitoring Systems, Inc. reported its financial results for the first quarter of fiscal year 2025, ending October 31, 2024.
• The company experienced a net loss of $77,000 for the quarter, compared to a net loss of $88,000 for the same period in the previous year.
• General and administrative expenses decreased to $63,000 from $75,000 year-over-year, primarily due to reduced insurance premiums.
• The company's total operating costs and expenses were $63,000 for the quarter, down from $75,000 in the prior year.
• Interest expense related to related-party promissory notes was $14,000, slightly up from $13,000 in the same quarter last year.
• The company's cash balance was $15,000 as of October 31, 2024, and it has a shareholders' deficit of $802,000.
• The company's independent auditor has expressed substantial doubt about the company's ability to continue as a going concern.
• The company is exploring potential mergers, acquisitions, and strategic collaborations to address its financial challenges.
• The company has negative working capital of approximately $802,000.
• The company believes that its current cash on hand is not sufficient to meet its anticipated cash requirements for the next 12 months.

Sentiment

Score: 2

Explanation: The document expresses significant concerns about the company's financial health, including a going concern warning, negative working capital, and low cash reserves. The company is reliant on related party debt and has material weaknesses in internal controls. The sentiment is very negative.

Positives

• The net loss decreased slightly year-over-year, from $88,000 to $77,000.
• General and administrative expenses decreased by $12,000 due to lower insurance premiums.

Negatives

• The company has a significant shareholders' deficit of $802,000.
• The company's cash balance is very low at $15,000.
• The company's independent auditor has expressed substantial doubt about the company's ability to continue as a going concern.
• The company has negative working capital of approximately $802,000.
• The company's current cash on hand is not sufficient to meet its anticipated cash requirements for the next 12 months.

Risks

• The company's ability to continue as a going concern is in substantial doubt.
• The company has a history of losses and an accumulated deficit.
• The company is dependent on management.
• The company needs additional financing to continue operations.
• The company faces risks related to proprietary rights.
• The company's internal controls over financial reporting are not effective due to a material weakness.
• The company may not be able to secure additional financing on acceptable terms or at all.
• Sales of equity or convertible debt securities may result in dilution to existing stockholders.

Future Outlook

The company expects to incur losses for the foreseeable future and will likely need to obtain additional external financing through public or private equity offerings, debt financings, or collaborative agreements. There is no assurance that such financing will be available on acceptable terms or at all.

Management Comments

• Management believes that the consolidated financial statements fairly present the company's financial condition, results of operations, and cash flows despite material weaknesses in internal control.
• Management is exploring potential mergers, acquisitions, and strategic collaborations.

Industry Context

The company's situation is not uncommon for small, development-stage companies, particularly those that have discontinued their primary operations and are seeking strategic alternatives. The need for additional financing and the going concern uncertainty are typical challenges faced by such entities.

Comparison to Industry Standards

• The company's negative working capital of $802,000 is a significant concern, indicating a potential inability to meet short-term obligations, which is worse than many comparable companies.
• The company's cash balance of $15,000 is extremely low, suggesting a high risk of immediate liquidity issues, which is worse than most comparable companies.
• The company's reliance on related-party debt financing is not unusual for small companies, but the high interest rate of 11% may be a concern.
• The company's lack of revenue and ongoing losses are typical for a shell company, but the magnitude of the losses and the going concern issue are significant red flags.
• The company's internal control weaknesses are a serious issue, indicating a lack of proper oversight and risk management, which is worse than most comparable companies.

Related Party Transactions

• The company is provided office space by a company controlled by Dr. Phillip Frost, a major shareholder, without recording rent expense.
• The company has outstanding notes payable to Frost Gamma Investments Trust, controlled by Dr. Phillip Frost, and to Dr. Jane Hsiao, the company's Chairman and Interim CEO.
• The company's Chief Financial Officer also serves as the Chief Financial Officer and Co-Chief Executive Officer of Cocrystal Pharma, Inc., where Dr. Frost is on the Board.

Stakeholder Impact

• Shareholders face significant risk due to the company's financial instability and going concern uncertainty.
• Employees may be impacted by potential restructuring or layoffs if the company cannot secure additional funding.
• Creditors face increased risk of non-payment due to the company's negative working capital and low cash reserves.
• The company's ability to pursue strategic collaborations is uncertain due to its financial challenges.

Next Steps

• The company is seeking potential mergers, acquisitions, and strategic collaborations.
• The company is exploring promissory notes and other opportunities for additional capital.

Key Dates

Keywords

going concern, financial statements, net loss, promissory notes, related party transactions, internal control, shareholders deficit, cash flow, mergers, acquisitions